Enfortumab Vedotin Shows Promise for Urothelial Carcinoma ...Middle East

Medscape - News
The antibody-drug conjugate enfortumab vedotin is superior to chemotherapy in patients with previously treated advanced urothelial carcinoma, primary results of the EV-301 trial show. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Enfortumab Vedotin Shows Promise for Urothelial Carcinoma )

Apple Storegoogle play

Also on site :

Most viewed in News